The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance
Open accessAbstract
The threat to human health posed by antibiotic resistance is of growing concern. Many commensal and pathogenic organisms have developed resistance to well established and newer antibiotics. The major selection pressure driving changes in the frequency of antibiotic resistance is the volume of drug use. However, establishing a quantitative relationship between the frequency of resistance and volume of drug use has proved difficult. Using population genetic methods and epidemiological observations, we report an analysis of the influence of the selective pressure imposed by the volume of drug use on temporal changes in resistance. Analytical expressions are derived to delineate key relationships between resistance and drug consumption. The analyses indicate that the time scale for emergence of resistance under a constant selective pressure is typically much shorter than the decay time after cessation or decline in the volume of drug use and that significant reductions in resistance require equally significant reductions in drug consumption. These results highlight the need for early intervention once resistance is detected.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infectious Diseases of Humans: Dynamics and Control
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-174_4 · Cited by 7,746
Press, W. H., Teukolsky, S. L. A., Flannery, B. P., & Vetterling, W. T. (1990) · Infoscience (Ecole Polytechnique Fédérale de Lausanne) · Cited by 6,980
Infectious Diseases of Humans: Dynamics and Control
Anderson, R. M., & May, R. M. (1991) · doi:10.1093/oso/9780198545996.001.0001 · Cited by 6,179
Self-citationThe crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial Era
Cohen, M. L. (1992) · Science · doi:10.1126/science.257.5073.1050 · Cited by 1,304
Seppälä, H., Klaukka, T., Vuopio-Varkila, J., Muotiala, A., Helenius, H., Lager, K., & Huovinen, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370701 · Cited by 1,206
Antimicrobial Resistance in Hospital Organisms and Its Relation to Antibiotic Use
McGowan, J. E. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.6.1033 · Cited by 605
Arason, V. A., Kristinsson, K. G., Sigurdsson, J. A., Stefansdottir, G., Molstad, S., & Gudmundsson, S. (1996) · BMJ · doi:10.1136/bmj.313.7054.387 · Cited by 492
Self-citationEvaluating treatment protocols to prevent antibiotic resistance
Bonhoeffer, S., Lipsitch, M., & Levin, B. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12106 · Cited by 487
Adaptation to the fitness costs of antibiotic resistance in Escherichia coli
Schrag, S. J., Perrot, V., & Levin, B. R. (1997) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1997.0178 · Cited by 396
Control Strategies for Tuberculosis Epidemics: New Models for Old Problems
Blower, S. M., Small, P. M., & Hopewell, P. C. (1996) · Science · doi:10.1126/science.273.5274.497 · Cited by 350
Virulence of antibiotic-resistant Salmonella typhimurium
Björkman, J., Hughes, D., & Andersson, D. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3949 · Cited by 343
Soares, S., Kristinsson, K. G., Musser, J. M., et al. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.1.158 · Cited by 323
Self-citationThe Population Genetics of Antibiotic Resistance
Levin, B. R., Lipsitch, M., Perrot, V., Schrag, S., Antia, R., Simonsen, L., Moore Walker, N., & Stewart, F. M. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s9 · Cited by 314
Jorgensen, J. H., Doern, G. V., Maher, L. A., Howell, A. W., & Redding, J. S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2075 · Cited by 310
Reducing antibiotic resistance
Schrag, S. J., & Perrot, V. (1996) · Nature · doi:10.1038/381120b0 · Cited by 254
Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital
Gerding, D. N., Larson, T. A., Hughes, R. A., Weiler, M., Shanholtzer, C., & Peterson, L. R. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1284 · Cited by 246
Reasons for the Emergence of Antibiotic Resistance
Tenover, F. C., & McGowan, J. E. (1996) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199601000-00003 · Cited by 204
Superinfection, Metapopulation Dynamics, and the Evolution of Diversity
May, R. M., & Nowak, M. A. (1994) · Journal of Theoretical Biology · doi:10.1006/jtbi.1994.1171 · Cited by 203
Effect of Antimicrobial Use and Other Risk Factors on Antimicrobial Resistance in Pneumococci
Kristinsson, K. G. (1997) · Microbial Drug Resistance · doi:10.1089/mdr.1997.3.117 · Cited by 166
Self-citationEpidemic methicillin-resistant Staphylococcus aureus
Cookson, B., & Phillips, I. R. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/21.suppl_c.57 · Cited by 162
Austin, D. J., Kakehashi, M., & Anderson, R. M. (1997) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1997.0227 · Cited by 149
Self-citationPredicting and preventing the emergence of antiviral drug resistance in HSV-2
Blower, S. M., Porco, T. C., & Darby, G. K. (1998) · Nature Medicine · doi:10.1038/nm0698-673 · Cited by 128
Modeling the Spread of Resistant Nosocomial Pathogens in an Intensive-Care Unit
Sebille, V., Chevret, S., & Valleron, A. (1997) · Infection Control and Hospital Epidemiology · doi:10.1086/647560 · Cited by 126
Emergence of Drug Resistance during an Influenza Epidemic: Insights from a Mathematical Model
Stilianakis, N. I., Perelson, A. S., & Hayden, F. G. (1998) · The Journal of Infectious Diseases · doi:10.1086/515246 · Cited by 125
Baquero, F. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.suppl_a.117 · Cited by 123
Nissinen, A. E. T., Grönroos, P., Huovinen, P., Herva, E., Katila, M., Klaukka, T., Kontiainen, S., Liimatainen, O., Oinonen, S., & Mäkelä, P. H. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.5.1193 · Cited by 53
Modeling and simulating the evolution of resistance against antibiotics
Massad, E., Lundberg, S., & Yang, H. M. (1993) · International Journal of Bio-Medical Computing · doi:10.1016/0020-7101(93)90060-j · Cited by 50
Cited by
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
Goossens, H., Ferech, M., Vander Stichele, R., & Elseviers, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17907-0 · Cited by 3,359
Call of the wild: antibiotic resistance genes in natural environments
Allen, H. K., Donato, J., Wang, H. H., Cloud-Hansen, K. A., Davies, J., & Handelsman, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2312 · Cited by 2,361
Probiotic bacteria: safety, functional and technological properties
Saarela, M., Mogensen, G., Fondén, R., Mättö, J., & Mattila-Sandholm, T. (2000) · Journal of Biotechnology · doi:10.1016/s0168-1656(00)00375-8 · Cited by 1,202
The biological cost of antibiotic resistance
Andersson, D. I., & Levin, B. R. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00005-3 · Cited by 867
Molecular Properties of Bacterial Multidrug Transporters
Putman, M., van Veen, H. W., & Konings, W. N. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.672-693.2000 · Cited by 795
Metadata
- Authors
- Austin, D. J., Kristinsson, K. G., & Anderson, R. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-02-02
- Volume
- 96
- Issue
- 3
- Pages
- 1152-1156
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2001700040
- Cited by
- 784
- References
- 29
- FWCI
- 37.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.